Comparative effectiveness for early-stage NSCLC without lymph node involvement based on prospective studies
These findings suggest the combination of systemic therapies, such as surgery plus ATKI or SBRT plus immunotherapy, superior approaches for patients with eNSCLC-N0 depending on the genomic mutation status and patient tolerability.
Authors
- Deying Kang (ORCID: https://orcid.org/0000-0003-1488-7047)
- Xue Yang (ORCID: https://orcid.org/0000-0002-9775-5009)
- Kailin Deng (ORCID: https://orcid.org/0000-0001-6614-8532)
- Shaohua Long (ORCID: https://orcid.org/0000-0001-5956-4562)
- Zhichao Xing (ORCID: https://orcid.org/0000-0003-0638-4597)
- Feng‐Ming Kong (ORCID: https://orcid.org/0000-0003-2652-098X)
- Xiaoxi Yu (ORCID: https://orcid.org/0000-0002-9193-9616)
- Nanhao Yin (ORCID: https://orcid.org/0009-0004-5995-595X)
- Ren Luo (ORCID: https://orcid.org/0000-0003-2952-6543)
- You Lu
- Jianxin Xue
Institutions
- Sichuan University (CN)
- West China Hospital of Sichuan University (CN)
- Stomatology Hospital (CN)
- University of Hong Kong - Shenzhen Hospital (CN)
- University of Hong Kong (HK)
Publication Details
- Journal
- International Journal of Surgery
- Published
- 2025-05-28
- DOI
- https://doi.org/10.1097/js9.0000000000002594
- Citations
- 1
- Primary Topic
- Lung Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.52